EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A mechanistic study on the enhanced antihypertensive effects of a Dendrobium officinale compound combined with Western antihypertensive drugs in spontaneously hypertensive rats based on metabolomics and gut microbiota analysis

Renzhao Wu, Cheng Tong, Zedong Gong, Jing Wang, Jie Wang, Tuo Feng, Xiaomin Xue, Xiyu Mei, Zhongxiu Guo, Yue Wu, Shuwei Huang, Caicai Xi

Frontiers in Cell and Developmental Biology · 15.06.2026 · 14

DOI: 10.3389/fcell.2026.1806395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 15.06.2026. Verfasst von Renzhao Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In our previously published research, we reported that the combination of Dendrobium Officinale Compound (DOC) and antihypertensive medications (irbesartan and amlodipine besylate) significantly and stably regulates blood pressure in spontaneously hypertensive rats (SHRs). This study aims to further explore the unique mechanisms and pathway networks underlying the antihypertensive effects of this combination therapy at the molecular level, based on serum and ileocecal contents metabolomics as well as gut microbiota analysis.

Methods

Utilizing UPLC-Q-TOF/MS and metabolomics techniques, we collected, analyzed, and integrated metabolite data to identify differential small molecule metabolites. High-throughput sequencing of the 16S rRNA gene was employed to characterize differences in gut microbiota composition among experimental animals subjected to distinct pharmacological interventions, and further elucidating the underlying antihypertensive mechanism network associated with the combined administration of DOC and conventional antihypertensive drugs.

Results

Metabolomic analyses revealed substantial differences in the profiles of low-molecular-weight metabolites in both serum and ileocecal contents across all treatment groups compared with the model control group. The antihypertensive effects of medium- and high-dose DOC in SHRs were associated with differential metabolites including L-tyrosine, L-methionine, and L-arginine; in contrast, the enhanced antihypertensive effect observed upon combination therapy with DOC and Western antihypertensive drugs correlated with distinct metabolites such as pregnenolone, creatine, and L-phenylalanine. 16S rRNA gene high-throughput sequencing of ileocecal contents indicated that the relative abundance of Firmicutes increased by 8.73%, 0.84%, and 10.40% following low-, medium-, and high-dose DOC interventions, respectively, relative to the model group; however, combination therapy with DOC and Western antihypertensive drugs resulted in an 8.80% decrease in Firmicutes abundance compared with the model group. Conversely, the relative abundance of Bacteroidetes decreased by 7.60%, 3.31%, and 7.67% after low-, medium-, and high-dose DOC treatments, respectively, versus the model group; yet, combination therapy led to a 7.05% increase in Bacteroidetes abundance relative to the model group.

Conclusion

Metabolomic and 16S rRNA sequencing analyses revealed that these effects may be linked to DOC’s specific modulation of serum amino acid profiles and remodeling of gut microbiota composition in PCAs. These findings provide new mechanistic insights into this traditional herb’s antihypertensive action.

Schlagwörter

Stichwörter der Autor:innen

Dendrobium officinale compoundenhanced antihypertensive effectsgut microbiotametabolomicsspontaneously hypertensive

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
  • Zhejiang Academy of Traditional Chinese Medicine, Hangzhou, China.
  • Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for Pharmacodynamic Material Basis Research of Chinese Medicine, Hangzhou, China.
  • The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • Clinical Pharmacy Department, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.

Zitieren

APA

Wu, R., Tong, C., Gong, Z., Wang, J., Wang, J., Feng, T., Xue, X., Mei, X., Guo, Z., Wu, Y., Huang, S., & Xi, C. (2026). A mechanistic study on the enhanced antihypertensive effects of a Dendrobium officinale compound combined with Western antihypertensive drugs in spontaneously hypertensive rats based on metabolomics and gut microbiota analysis. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1806395

Vancouver

Wu R, Tong C, Gong Z, Wang J, Wang J, Feng T, et al. A mechanistic study on the enhanced antihypertensive effects of a Dendrobium officinale compound combined with Western antihypertensive drugs in spontaneously hypertensive rats based on metabolomics and gut microbiota analysis. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1806395

BibTeX
@article{Wu2026,
  author = {Wu, Renzhao and Tong, Cheng and Gong, Zedong and Wang, Jing and Wang, Jie and Feng, Tuo and Xue, Xiaomin and Mei, Xiyu and Guo, Zhongxiu and Wu, Yue and Huang, Shuwei and Xi, Caicai},
  title = {A mechanistic study on the enhanced antihypertensive effects of a Dendrobium officinale compound combined with Western antihypertensive drugs in spontaneously hypertensive rats based on metabolomics and gut microbiota analysis},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1806395}
}
Kostenlos starten →